Latest Breaking News On - Ophthalmology division of sanofi - Page 1 : comparemela.com

GenSight Biologics SA (GSGTF) is Developing the Leber Hereditary Optic Neuropathy Cure

Interview with Bernard Gilly the Co-Founder and CEO: GenSight Biologics SA (OTCMKTS:GSGTF) describes the status of their mitochondrial drug treatments.

United statesSean donahueEcole nationaleGensight biologicsBernard gillyNouveau marcheFovea pharmaceuticalsEuropean medicines agencyAmerican academy of ophthalmology conferenceOphthalmology division of sanofiLeber hereditary optic neuropathyGensight biologicChief executive officerPixium visionGecko biomedicalSenior vice president

Interview with the Co-Founder and CEO: GenSight Biologics SA (OTCMKTS:GSGTF)

Interview with the Co-Founder and CEO: GenSight Biologics SA (OTCMKTS:GSGTF)
twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.

Ecole nationaleBernard gillyNouveau marcheFovea pharmaceuticalsOphthalmology division of sanofiGensight biologicsGensight biologicChief executive officerPixium visionGecko biomedicalSenior vice presidentOphthalmology divisionEuronext paris

Braintale Appoints Industry Leaders Spyros Artavanis-Tsakonas and Nitza Thomasson to Its Board of Directors

Braintale, an innovative French company dedicated to neurological disorders and management of brain injured patients with its portfolio of solutions in neurology and intensive care, announces the appointment

United kingdomUnited statesFrance generalVincent perlbargNitza thomassonJulie rachlineKostenloser wertpapierhandelGensight biologicsSpyros artavanis tsakonasFondation santeInstitut curieBiogen incNorthwestern rush university chicagoAcademy of athensRegenerative biology program at harvard medical schoolYale school of medicine